Appili Therapeutics Stock Market Value
| APLI Stock | CAD 0.01 0.01 25.00% |
| Symbol | Appili |
Appili Therapeutics Price To Book Ratio
Appili Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Appili Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Appili Therapeutics.
| 04/20/2025 |
| 07/19/2025 |
If you would invest 0.00 in Appili Therapeutics on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding Appili Therapeutics or generate 0.0% return on investment in Appili Therapeutics over 90 days. Appili Therapeutics is related to or competes with Cardiol Therapeutics, and Medicenna Therapeutics. Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for... More
Appili Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Appili Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Appili Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 66.67 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 20.0 |
Appili Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Appili Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Appili Therapeutics' standard deviation. In reality, there are many statistical measures that can use Appili Therapeutics historical prices to predict the future Appili Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (2.05) | |||
| Treynor Ratio | (1.01) |
Appili Therapeutics Backtested Returns
Appili Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0207, which signifies that the company had a -0.0207 % return per unit of risk over the last 3 months. Appili Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Appili Therapeutics' Mean Deviation of 6.11, risk adjusted performance of (0.01), and Standard Deviation of 13.09 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Appili Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Appili Therapeutics is expected to be smaller as well. At this point, Appili Therapeutics has a negative expected return of -0.27%. Please make sure to confirm Appili Therapeutics' maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Appili Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.26 |
Weak reverse predictability
Appili Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Appili Therapeutics time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Appili Therapeutics price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Appili Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Appili Therapeutics lagged returns against current returns
Autocorrelation, which is Appili Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Appili Therapeutics' stock expected returns. We can calculate the autocorrelation of Appili Therapeutics returns to help us make a trade decision. For example, suppose you find that Appili Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Appili Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Appili Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Appili Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Appili Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Appili Therapeutics Lagged Returns
When evaluating Appili Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Appili Therapeutics stock have on its future price. Appili Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Appili Therapeutics autocorrelation shows the relationship between Appili Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Appili Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Appili Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Appili Stock
Moving against Appili Stock
| 0.81 | GOOG | Alphabet CDR Earnings Call This Week | PairCorr |
| 0.8 | META | Meta Platforms CDR | PairCorr |
| 0.8 | NVDA | NVIDIA CDR | PairCorr |
| 0.77 | AMZN | Amazon CDR | PairCorr |
| 0.76 | MSFT | Microsoft Corp CDR | PairCorr |
The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.
The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.